Indole Forte
Withdrawn from the US market on 18 February 2025 (according to the DSLD)
Klaire Labs, food supplement from the US market
Label withdrawn from the US market. Indole Forte (Klaire Labs), a food supplement au code-barres 828054006300, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- À vérifier
Indole-3-carbinol is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-00429.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Klaire Labs
- Barcode
- 828054006300
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hydroxypropylmethylcellulose, Water, Microcrystalline Cellulose, Ascorbyl Palmitate, Silicon Dioxide
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Total Dietary Indoles | Blend | 400 mg |
| Indole-3-Carbinol | Other substance | not stated |
| Diindolylmethane | Other substance | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Indole Forte
Entered into DSLD on 19 May 2022. Withdrawn from the US market on 18 March 2022 (according to the DSLD).Same active composition.
Official label: Indole Forte
Entered into DSLD on 24 February 2017. Withdrawn from the US market on 8 October 2021 (according to the DSLD).- Active ingredient added : Proprietary Blend containing (quantity not stated)
- Active ingredient added : related Indole compounds (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Klaire Labs
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Indole Forte : étiquette retirée du marché américain (Klaire Labs): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/828054006300-indole-forte-klaire-labs, updated 18 February 2025.